AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies Founded by Jonathan Jones in 2019, AviadoBio is backed by F-Prime Capital, New Enterprise Associates, Dementia Discovery Fund, Johnson & Johnson Innovation â JJDC, and LifeArc and is headquartered in London.